Condition: Hidradenitis Suppurativa · Sponsor: Institut Pasteur
The study evaluates the efficacy of an adapted antibiotherapy in Hurley stage 2 active Hidradenitis Suppurativa patients versus tetracycline derivative
This description comes directly from the study's public registry record.
Maïa Delage-Toriel, MD · +33 1 40 61 30 77 · maia.delage-toriel@pasteur.fr
Aude Nassif, MD · 01 40 61 30 77 · aude.nassif@pasteur.fr
Always discuss trial participation with your own doctor first.
| Hôpital de la Timone | Marseille, France | Not Yet Recruiting |
| Centre Médical de l'Institut Pasteur | Paris, France | Recruiting |
| Hopital St Joseph | Paris, France | Active Not Recruiting |
| CHU de Rouen | Rouen, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05821478